Extracorporeal Membrane Oxygenation for Secondary Organizing Pneumonia after Severe SARS-CoV-2 Infection: A Case Report

Medicina

Koichi Ohsugi¹  Yuki Ichikawa¹  Toru Kotani¹  Taro Watanabe¹  Atsuko Shono¹  Tomoko Kawahara²  Tomoyuki Kimura²  Yosuke Fukuda²  Tetsuya Homma²  Chisato Onitsuka²  Hironori Sagara² 

[1] Department of Intensive Care Medicine, Showa University School of Medicine, Tokyo 142-0064, Japan;Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo 142-0064, Japan;

关键词: SARS-CoV-2;    COVID-19;    organizing pneumonia;    ECMO;    dexamethasone;   

DOI  :  10.3390/medicina57101013

来源: DOAJ

【 摘 要 】

(Background) COVID-19 is caused by SARS-CoV-2 infection and may result in unfavorable outcomes. A recent large-scale study showed that treatment with dexamethasone leads to favorable outcomes in patients with severe COVID-19, and the use of extracorporeal membrane oxygenation (ECMO) has also been shown to improve outcomes. Recently, secondary organizing pneumonia (SOP) has been reported after SARS-CoV-2 infection, but the diagnostic and treatment strategies are still unclear. (Case presentation) Here, we report a patient with severe COVID-19 who developed SOP even after the use of dexamethasone, for whom the introduction of ECMO on the 19th day after hospitalization led to a favorable outcome. (Conclusions) Life-threatening SOP may evolve even after the use of dexamethasone, and the late-phase introduction of ECMO may save such patients with COVID-19.

【 授权许可】

Unknown